Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Coya Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/21/2023 |
4
| Weinand Dieter (Director) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.43, valued at
$34.3k
|
|
| 08/21/2023 |
3
| Weinand Dieter (Director) has filed a Form 3 on Coya Therapeutics, Inc. |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/01/2023 |
4
| Berman Howard (CEO) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Granted 165,000 options to buy
@ $3.85, valued at
$635.3k
|
|
| 03/01/2023 |
4
| Hepner Adrian (Chief Medical Officer) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Granted 115,000 options to buy
@ $3.85, valued at
$442.8k
|
|
| 03/01/2023 |
4
| SNYDER DAVID S (CFO) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Granted 115,000 options to buy
@ $3.85, valued at
$442.8k
|
|
| 01/17/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/04/2023 |
4
| Berman Howard (CEO) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0
Bought 5,000 options to buy
@ $7.5, valued at
$37.5k
|
|
| 01/04/2023 |
4
| Lee Ann (Director) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0
Converted 6,479 shares
@ $4, valued at
$25.9k
Bought 5,000 options to buy
@ $7.5, valued at
$37.5k
Converted convertible notes
@ $0 |
|
| 01/04/2023 |
4
| Hepner Adrian (Chief Medical Officer) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0
Bought 5,000 options to buy
@ $7.5, valued at
$37.5k
|
|
| 01/04/2023 |
4
| Garren Hideki (Director) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $0
Bought 1,000 options to buy
@ $7.5, valued at
$7.5k
|
|
| 01/04/2023 |
4
| SNYDER DAVID S (CFO) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Bought 7,000 shares
@ $0
Bought 3,500 options to buy
@ $7.5, valued at
$26.3k
|
|
| 01/04/2023 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0
Bought 5,000 options to buy
@ $7.5, valued at
$37.5k
|
|
| 01/04/2023 |
4
| Villalobos Anabella (Director) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0
Bought 5,000 options to buy
@ $7.5, valued at
$37.5k
|
|
| 12/28/2022 |
3
| Bertex LLC (10% Owner) has filed a Form 3 on Coya Therapeutics, Inc. |
| 12/28/2022 |
3
| SNYDER DAVID S (CFO) has filed a Form 3 on Coya Therapeutics, Inc. |
| 12/28/2022 |
3
| Lee Ann (Director) has filed a Form 3 on Coya Therapeutics, Inc. |
| 12/28/2022 |
3
| Garren Hideki (Director) has filed a Form 3 on Coya Therapeutics, Inc. |
| 12/28/2022 |
3
| Hepner Adrian (Chief Medical Officer) has filed a Form 3 on Coya Therapeutics, Inc. |
| 12/28/2022 |
3
| GOLDSTEIN DOV A MD (Director) has filed a Form 3 on Coya Therapeutics, Inc. |
| 12/28/2022 |
3
| Berman Howard (CEO) has filed a Form 3 on Coya Therapeutics, Inc. |
| 12/28/2022 |
3
| Villalobos Anabella (Director) has filed a Form 3 on Coya Therapeutics, Inc. |
|
|